- Home
- OSBC vs SVRA Comparison
OSBC vs SVRA Comparison
Compare OSBC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSBC | SVRA |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OSBC | SVRA |
|---|---|---|
| Price | $20.39 | $5.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $21.63 | $7.33 |
| AVG Volume (30 Days) | 290.3K | ★ 1.9M |
| Earning Date | 01-21-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.37% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $288,832,000.00 | N/A |
| Revenue This Year | $27.60 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | $13.79 | ★ N/A |
| Revenue Growth | ★ 9.38 | N/A |
| 52 Week Low | $14.14 | $1.89 |
| 52 Week High | $21.10 | $7.01 |
Technical Indicators
Market Signals| Indicator | OSBC | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 51.77 |
| Support Level | $20.21 | $5.53 |
| Resistance Level | $21.10 | $6.09 |
| Average True Range (ATR) | 0.57 | 0.30 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 60.21 | 54.60 |
Price Performance
Historical ComparisonAbout OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.